# Vascular Anomalies and Treatments **Type:** Topics **Canonical URL:** https://scholariq.org/topics/vascular-anomalies-and-treatments/ ## Facts | Field | Value | | --- | --- | | Description | This cluster of papers focuses on the diagnosis and management of hereditary hemorrhagic telangiectasia (HHT), a genetic disorder characterized by vascular malformations. It covers topics such as genetics, pulmonary arteriovenous malformations, embolization, epistaxis, liver involvement, SMAD4 mutations, and vascular anomalies. | | Domain | Health Sciences | | Field | Medicine | | OpenAlex ID | t12199 | | Works | 94 | ## Topic papers all Showing 15 of 94. - [Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1](https://scholariq.org/papers/endoglin-a-tgf-binding-protein-of-endothelial-cells-is-the-gene-for-hereditary/) - [Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial](https://scholariq.org/papers/continuous-subcutaneous-infusion-of-treprostinil-a-prostacyclin-analogue-in/) - [Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2](https://scholariq.org/papers/mutations-in-the-activin-receptor-like-kinase-1-gene-in-hereditary-haemorrhagic/) - [International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia](https://scholariq.org/papers/international-guidelines-for-the-diagnosis-and-management-of-hereditary/) - [A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma](https://scholariq.org/papers/a-randomized-controlled-trial-of-oral-propranolol-in-infantile-hemangioma/) - [Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma](https://scholariq.org/papers/radioembolization-results-in-longer-time-to-progression-and-reduced-toxicity/) - [Pulmonary Endarterectomy: Recent Changes in a Single Institution's Experience of More Than 2,700 Patients](https://scholariq.org/papers/pulmonary-endarterectomy-recent-changes-in-a-single-institution-s-experience-of/) - [Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis](https://scholariq.org/papers/mycophenolate-mofetil-vs-azathioprine-for-remission-maintenance-in/) - [Maternal Outcome After Conservative Treatment of Placenta Accreta](https://scholariq.org/papers/maternal-outcome-after-conservative-treatment-of-placenta-accreta/) - [Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis](https://scholariq.org/papers/plasmapheresis-therapy-for-diffuse-alveolar-hemorrhage-in-patients-with-small/) - [Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device](https://scholariq.org/papers/arteriovenous-malformation-and-gastrointestinal-bleeding-in-patients-with-the/) - [Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival](https://scholariq.org/papers/bone-morphogenetic-protein-receptor-2-signaling-promotes-pulmonary-arterial/) - [A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia](https://scholariq.org/papers/a-multicenter-randomized-clinical-trial-of-hormonal-therapy-in-the-prevention-of/) - [Argon Plasma Coagulation in the Management of Symptomatic Gastrointestinal Vascular Lesions: Experience in 100 Consecutive Patients with Long-Term Follow-Up](https://scholariq.org/papers/argon-plasma-coagulation-in-the-management-of-symptomatic-gastrointestinal/) - [Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia](https://scholariq.org/papers/pulmonary-arteriovenous-malformations-in-hereditary-hemorrhagic-telangiectasia/) ## Topic primary papers Showing 15 of 25. - [Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1](https://scholariq.org/papers/endoglin-a-tgf-binding-protein-of-endothelial-cells-is-the-gene-for-hereditary/) - [Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2](https://scholariq.org/papers/mutations-in-the-activin-receptor-like-kinase-1-gene-in-hereditary-haemorrhagic/) - [International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia](https://scholariq.org/papers/international-guidelines-for-the-diagnosis-and-management-of-hereditary/) - [Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia](https://scholariq.org/papers/pulmonary-arteriovenous-malformations-in-hereditary-hemorrhagic-telangiectasia/) - [Clinical Practice Guideline: Nosebleed (Epistaxis)](https://scholariq.org/papers/clinical-practice-guideline-nosebleed-epistaxis/) - [Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview](https://scholariq.org/papers/diagnosis-and-treatment-of-pulmonary-arteriovenous-malformations-in-hereditary/) - [Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary](https://scholariq.org/papers/clinical-practice-guideline-nosebleed-epistaxis-executive-summary/) - [Lower Risk of Intracranial Arteriovenous Malformation Hemorrhage in Patients With Hereditary Hemorrhagic Telangiectasia](https://scholariq.org/papers/lower-risk-of-intracranial-arteriovenous-malformation-hemorrhage-in-patients/) - [Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta‐analysis](https://scholariq.org/papers/epistaxis-risk-associated-with-intranasal-corticosteroid-sprays-a-systematic/) - [Evaluation and Management of Hemoptysis in Infants and Children a Report of Nine Cases](https://scholariq.org/papers/evaluation-and-management-of-hemoptysis-in-infants-and-children-a-report-of-nine/) - [Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an “HHT‐like” syndrome in children](https://scholariq.org/papers/homozygous-i-gdf2-i-nonsense-mutations-result-in-a-loss-of-circulating-bmp9-and/) - [Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis Secondary to Tuberculosis](https://scholariq.org/papers/outcomes-of-bronchial-artery-embolization-for-life-threatening-hemoptysis/) - [Long-Term Single-Center Retrospective Follow-Up After Embolization of Pulmonary Arteriovenous Malformations Treated Over a 20-year Period: Frequency of Re-canalization with Various Embolization Materials and Clinical Outcome](https://scholariq.org/papers/long-term-single-center-retrospective-follow-up-after-embolization-of-pulmonary/) - [Recombinant Activated Factor VII for Massive Hemoptysis in Patients With Cystic Fibrosis](https://scholariq.org/papers/recombinant-activated-factor-vii-for-massive-hemoptysis-in-patients-with-cystic/) - [Randomized, controlled, double‐blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization](https://scholariq.org/papers/randomized-controlled-double-blinded-clinical-trial-of-effect-of-bevacizumab/) --- Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.